Connor, Clark & Lunn Investment Management (CC&L)’s ChemoCentryx, Inc. CCXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-56,739
| Closed | -$772K | – | 1122 |
|
|
2018
Q1 | $772K | Sell |
56,739
-7,760
| -12% | -$106K | ﹤0.01% | 511 |
|
|
2017
Q4 | $384K | Sell |
64,499
-1,276
| -2% | -$7.6K | ﹤0.01% | 657 |
|
|
2017
Q3 | $488K | Sell |
65,775
-20,300
| -24% | -$151K | ﹤0.01% | 644 |
|
|
2017
Q2 | $806K | Buy |
86,075
+16,625
| +24% | +$156K | 0.01% | 532 |
|
|
2017
Q1 | $506K | Buy |
69,450
+24,975
| +56% | +$182K | ﹤0.01% | 627 |
|
|
2016
Q4 | $329K | Buy |
44,475
+16,775
| +61% | +$124K | ﹤0.01% | 699 |
|
|
2016
Q3 | $167K | Buy |
+27,700
| New | +$167K | ﹤0.01% | 749 |
|